Dr Duncan Scott

Duncan obtained his PhD in Chemistry from the University of Cambridge in the laboratory of Professor Chris Abell, working on fragment-based drug discovery programmes against challenging targets. He went on to lead a multidisciplinary drug discovery team at the University, targeting a protein-protein interaction with a fragment-based approach. He joined the ALBORADA Drug Discovery Institute in 2016, where he currently leads a drug discovery team. His research interests include drug discovery, medicinal chemistry, biophysics and neurodegeneration.